Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Jan;79(1):54–56. doi: 10.1136/bjo.79.1.54

Adverse ocular effects associated with niacin therapy.

F W Fraunfelder 1, F T Fraunfelder 1, D R Illingworth 1
PMCID: PMC505021  PMID: 7880795

Abstract

In a retrospective survey of patients taking medication for hyperlipidaemia, those taking niacin (nicotinic acid) were more likely (p < 0.05) to report sicca syndromes, blurred vision, eyelid oedema, and macular oedema compared with those who never took niacin. Additionally, 7% of those taking niacin discontinued the drug owing to adverse ocular side effects, while none of the other lipid lowering agents were found to cause these side effects (p = 0.016). Data from spontaneous reporting systems support a possible association of decreased vision, cystoid macular oedema, sicca-like symptoms, discoloration of the eyelids with or without periorbital or eyelid oedema, proptosis, loss of eyebrow or eyelashes, and superficial punctate keratitis with the use of niacin in high doses. Decreased vision may be marked, and if the drug is not discontinued, may progress to cystoid macular oedema. All ocular side effects listed above are reversible if the association with niacin is recognised and the drug is discontinued; both the incidence and severity of the ocular side effects seem to be dose dependent.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHAZIN B. J. Effect of nicotinic acid on blood cholesterol. Geriatrics. 1960 Jun;15:423–429. [PubMed] [Google Scholar]
  2. Gass J. D. Nicotinic acid maculopathy. Am J Ophthalmol. 1973 Oct;76(4):500–510. doi: 10.1016/0002-9394(73)90738-1. [DOI] [PubMed] [Google Scholar]
  3. HARRIS J. L. Toxic amblyopia associated with administration of nicotinic acid. Am J Ophthalmol. 1963 Jan;55:133–134. doi: 10.1016/0002-9394(63)91658-1. [DOI] [PubMed] [Google Scholar]
  4. Jampol L. M. Niacin maculopathy. Ophthalmology. 1988 Dec;95(12):1704–1705. doi: 10.1016/s0161-6420(88)32955-6. [DOI] [PubMed] [Google Scholar]
  5. Millay R. H., Klein M. L., Illingworth D. R. Niacin maculopathy. Ophthalmology. 1988 Jul;95(7):930–936. doi: 10.1016/s0161-6420(88)33073-3. [DOI] [PubMed] [Google Scholar]
  6. PARSONS W. B., Jr, FLINN J. H. Reduction in elevated blood cholesterol levels by large doses of nicotinic acid; preliminary report. J Am Med Assoc. 1957 Sep 21;165(3):234–238. doi: 10.1001/jama.1957.02980210030009. [DOI] [PubMed] [Google Scholar]
  7. Ubels J. L., MacRae S. M. Vitamin A is present as retinol in the tears of humans and rabbits. Curr Eye Res. 1984 Jun;3(6):815–822. doi: 10.3109/02713688409000793. [DOI] [PubMed] [Google Scholar]
  8. Wysowski D. K., Kennedy D. L., Gross T. P. Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. JAMA. 1990 Apr 25;263(16):2185–2188. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES